Meta-analysis of individual participant data: Rationale, conduct, and reporting

BMJ (Online)

Volumn 340, Issue 7745, 2010, Pages 521-525

  Riley, Richard D ^a   Lambert, Paul C ^b   Abo Zaid, Ghada ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLUSTER ANALYSIS; DATA ANALYSIS; EVIDENCE BASED MEDICINE; LINEAR REGRESSION ANALYSIS; MEDICAL RESEARCH; META ANALYSIS; PATIENT CODING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

BIAS (EPIDEMIOLOGY); DATA COLLECTION; META-ANALYSIS AS TOPIC; REVIEW LITERATURE AS TOPIC; RISK ASSESSMENT;

EID: 77749306261     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c221     Document Type: Article

References (39)

1. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418-22.
2. Oxman AD, Clarke MJ, Stewart LA. From science to practice. Meta-analyses using individual patient data are needed. JAMA 1995;274:845-6.
3. Simmonds MC, Higgins JPT, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005;2:209-17.
4. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med 2000;19:3417-32.
5. Higgins JP, Whitehead A, Turner RM, Omar RZ, Thompson SG. Meta-analysis of continuous outcome data from individual patients. Stat Med 2001;20:2219-41.
6. Whitehead A, Omar RZ, Higgins JP, Savaluny E, Turner RM, Thompson SG. Meta-analysis of ordinal outcomes using individual patient data. Stat Med 2001;20:2243-60.
7. Tudur-Smith C, Williamson PR, Marson AG. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med 2005;24(9):1307-19.
8. Jones AP, Riley RD, Williamson PR, Whitehead A. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials 2009;6:16-27.
9. Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, et al. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med 2008;27:1870-93.
10. Riley RD, Dodd SR, Craig JV, Thompson JR, Williamson PR. Meta-analysis of diagnostic test studies using individual patient data and aggregate data. Stat Med 2008;27:6111-36.
11. Olkin I, Sampson A. Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics 1998;54:317-22.
12. Mathew T, Nordstrom K. On the equivalence of meta-analysis using literature and using individual patient data. Biometrics 1999;55:1221-3.
13. Higgins JPT, Green S. Cochrane handbook for systematic reviews ofinterventions version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. www.cochrane-handbook.org.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
15. Riley RD, Simmonds MC, Look MP. Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol 2007;60:431-9.
16. McCormack K, Grant A, Scott N. Value of updating a systematic review in surgery using individual patient data. Br J Surg 2004;91:495-9.
17. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA 1995;274:830-6.
18. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 2002;21:371-87.
19. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 2002;55:86-94.
20. Davey Smith G, Egger M, Phillips AN. Meta-analysis. Beyond the grand mean? BMJ 1997;315:1610-4.
21. Thompson SG, Higgins JP. Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet 2005;365:341-6.
22. Ioannidis JP, Rosenberg PS, Goedert JJ, O'Brien TR. Meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol 2002;156:204-10.
23. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 2007:287-93.
24. Hernandez AV, Eijkemans MJ, Steyerberg EW. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Ann Epidemiol 2006;16:41-8.
25. Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: validating a prognostic model. BMJ 2009;338:b605.
26. Royston P, Parmar MKB, Sylvester R. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer. Stat Med 2004;23:907-26.
27. Stewart LA, Clarke MJ for the Cochrane Working Group. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1995;14:2057-79.
28. Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, et al. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 2002;94:116-28.
29. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
30. Moher D, Liberati A, Tetzlaff J, Altman DG for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
31. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al for the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008-12.
32. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005;45:907-13.
33. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow-up measurements. BMJ 2001;323:1123-4.
34. Abrams KR, Gillies CL, Lambert PC. Meta-analysis of heterogeneously reported trials assessing change from baseline. Stat Med 2005;24:3823-44.
35. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A 2009;172:137-59.
36. Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002;25:76-97.
37. Hutchon DJ. Publishing raw data and real time statistical analysis on e-journals. BMJ 2001;322:530.
38. Chia S, Bryce C, Gelmon K. The 2000 EBCTCG overview: a widening gap. Lancet 2005;365:1665-6.
39. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.